trial news

AGITG Trial News

Trial news: The AGITG currently has ten studies open to recruitment and ten studies in follow up.

The  table below details the trials that are currently accruing patients.

Recruited Target
ACTICCA-1- Gallbladder carcinoma 3 50
ASCOLT — Colorectal cancer 289 300
CONTROL NETs — NeuroEndocrine Tumour 70 75
INTEGRATE II –  Gastro-Oesophageal 32 90
NABNEC  — NeuroEndocrine Tumour 21 70
TOP GEAR — Stomach cancer 195 280
DYNAMIC-III 37 1,000
SPAR 1  222
LIBERATE 4 100

Trial Results Lay Summaries (click on the links below):Recruitment figures to end May 2018.


ALaCaRT

ATTACHE
ATTAX-3
GAP
ICECREAM
INTEGRATE
TACTIC
TOP GEAR
CO.17
EORTC 62024
Advanced GIST

Share